<DOC>
	<DOCNO>NCT01012440</DOCNO>
	<brief_summary>The purpose study : 1 . To evaluate hypothesis : Can PEM Flex Solo II PET scanner ascertain response neoadjuvant chemotherapy patient breast cancer ? 2 . To compare result PEM Flex Solo II PET scanner standard care bilateral breast MRI .</brief_summary>
	<brief_title>Role Positron Emission Mammography ( PEM ) Flex Solo II Positron Emission Tomography ( PET ) Scanner Evaluating Neoadjuvant Chemotherapy Response Patients With Breast Cancer</brief_title>
	<detailed_description>Subjects receive bilateral ( side ) breast axillary PEM scan . All recruited subject choose study biopsy proven breast cancer eligible chemotherapy . They undergo bilateral breast MRI staging consider standard care . Breast MRI PEM scan perform baseline ( phase 0 pre-operative phase ) , 2nd MRI PEM 1 2 week NAC ( phase 1 ) 3rd MRI PEM 1 2 week phase 1 ( phase 2 ) . DCE-MRI PEM perform 14 day apart within phase . Cranio-Caudal ( CC ) Medial Lateral Oblique ( MLO ) PEM view perform ipsilateral contralateral breast axilla Mammography Technologist train mammographic positioning .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Women 1875 year old newly diagnose breast cancer consider candidate breast conserve surgery ( i.e. , lumpectomy ) Children ( &lt; 18 year old ) Pregnant Lactating woman Diabetic patient ( Type I II ) Patients schedule sentinel node procedure use radioactive Tc99m within 24 hour PEM Patients NOT undergone standard care bilateral breast MRI</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>